4-bromo-3-methyl-1H-indole-6-carboxylic acid

Catalog No. :
ACCMSH045
CAS No. :
1360890-98-7
Molecular Formula :
C10H8BrNO2
Molecular Weight :
254.08

IUPAC Name:4-bromo-3-methyl-1H-indole-6-carboxylic acid

4-bromo-3-methyl-1H-indole-6-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$359.00Login to see priceIn stockInquiry
250mg95%$600.00Login to see priceInquiryInquiry
500mg95%$999.00Login to see priceInquiryInquiry
1g95%$1498.00Login to see priceInquiryInquiry
5g95%$4493.00Login to see priceInquiryInquiry
10g95%$7488.00Login to see priceInquiryInquiry
25g95%$14976.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-bromo-3-methyl-1H-indole-6-carboxylic acid
IUPAC Name4-bromo-3-methyl-1H-indole-6-carboxylic acid
MDL No.MFCD27987707
Molecular FormulaC10H8BrNO2
Molecular Weight254.08
SMILESCC1=CNC2=C1C(Br)=CC(=C2)C(O)=O
InChI KeyUXKHPSZBWPIAIW-UHFFFAOYSA-N
Synonym4-bromo-3-methyl-1H-indole-6-carboxylic acid | 1360890-98-7 | 4-bromo-3-methyl-1H-indole-6-carboxylicacid | SCHEMBL21439145 | MFCD27987707 | SB14886 | BS-43016 | CS-0050986 | P18384
CAS No.1360890-98-7
PubChem CID126970577

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCMSH045 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBKPY679 route compound structure diagram
    ACBKPY6791638759-59-7 In Stock
  2. Then
  3. ACCMSH045 route product structure diagram
    ACCMSH0451360890-98-7 In Stock
Inquiry

2. ACCMSH045 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCMSH045 route product structure diagram
    ACCMSH0451360890-98-7 In Stock
Inquiry

Comments (0)